Wikidata

(Q53674348)

English

Cost-effectiveness analysis of ranibizumab versus verteporfin photodynamic therapy, pegaptanib sodium, and best supportive care for the treatment of age-related macular degeneration in Greece.

scientific article published on 30 January 2012

In more languages

Statements

title
Cost-effectiveness analysis of ranibizumab versus verteporfin photodynamic therapy, pegaptanib sodium, and best supportive care for the treatment of age-related macular degeneration in Greece. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22289279
retrieved
17 May 2018
reference URL
http://europepmc.org/abstract/MED/22289279

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53674348&oldid=1905642005"